You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
This book describes the Proceedings of the International Conference on Nuclear Data for Science and Technology held at Jillich in May 1991. The conference was in a series of application oriented nuclear data conferences organized in the past under the auspices of the Nuclear Energy Agency-Nuclear Data Committee (NEANDC) and with the support of the Nuclear Energy Agency-Committee on Reactor Physics (NEACRP). It was the fIrst international conference on nuclear data held in Germany, with the scientific responsibility entrusted to the Institute of Nuclear Chemistry of the Research Centre Jillich. The scientific programme was established by the International Programme Committee in consultation w...
The work describes the production technology of standard medical radionuclides using reactors and cyclotrons for patient diagnosis and therapy. A special focus lies on the science and technology involved in the development of novel radionuclides for positron emission tomography (PET) and internal targeted radiotherapy. The availability of those radionuclides is opening up new potential in clinical research, especially in neurology, cardiology and oncology. The future perspectives of the developing technology are also discussed.
Radiochemical methodology constitutes the most important base for the successful functioning of a PET group in the routine production and development of radiopharmaceuticals. Of the several hundred products which have been labelled with positron emitters during the past two decades about 35 are presently considered to be of major interest. The time for a state-of-the-art review is right, since this field has advanced over the past fifteen years to reach a level where guidelines can now be suggested. Chapters of this book deal with each of the main methodological aspects of the chemistry needed to develop an effective radiopharmaceutical, namely radionuclide production, automation and metabol...
In the new edition of this very successful book, European and North American experts present the state of the art in diagnostic and therapeutic radionuclide procedures. The aim is to examine established and emerging clinical applications in detail, rather than to consider everything included in the comprehensive texts already available within the field. This “practical” approach ensures that the book will be a valuable guide for nuclear medicine physicians, technologists, students, and interested clinicians alike. This edition of Clinical Nuclear Medicine has been extensively revised to take account of recent developments. The roles of SPECT/CT, PET/CT, and PET/MRI are clearly explained and illustrated, and the coverage extended to encompass, for example, novel PET tracers and therapeutic radionuclides, advanced techniques of brain imaging, and the development of theranostics. Readers will be fully persuaded of the ever-increasing value of nuclear medicine techniques in depicting physiology and function and complementing anatomic modalities such as CT, MRI, and ultrasound.
This book highlights the advanced technologies and applications of neutron activation analysis (NAA). It discusses the latest developments influencing the performance and utility of different NAA techniques across wide areas of applications: nuclear technology, industry, medicine, clinical investigations, biology, geochemistry, soil contamination, waste management, diet, lifestyle and health, cosmology, archeology, forensic science, etc. The overall goal of the book is to promote innovation and development of NAA techniques, technologies, and nuclear culture by presenting high-quality chapters with numerous results at both national and international levels. The book will serve as a source for graduate and postgraduate students in nuclear sciences and applications and nuclear analytical techniques, experienced practitioners who want to implement or use other varieties of NAA, professional technicians and analysts, users of NAA, and other stakeholders who wish to better understand NAA techniques.
This revised and extended 6 volume handbook set is the most comprehensive and voluminous reference work of its kind in the field of nuclear chemistry. The Handbook set covers all of the chemical aspects of nuclear science starting from the physical basics and including such diverse areas as the chemistry of transactinides and exotic atoms as well as radioactive waste management and radiopharmaceutical chemistry relevant to nuclear medicine. The nuclear methods of the investigation of chemical structure also receive ample space and attention. The international team of authors consists of scores of world-renowned experts - nuclear chemists, radiopharmaceutical chemists and physicists - from Europe, USA, and Asia. The Handbook set is an invaluable reference for nuclear scientists, biologists, chemists, physicists, physicians practicing nuclear medicine, graduate students and teachers - virtually all who are involved in the chemical and radiopharmaceutical aspects of nuclear science. The Handbook set also provides further reading via the rich selection of references.
This compendium describes the major production routes of the six most relevant iodine radio isotopes and the various methods of labeling molecules of biological, diagnostic or pharmaceutical interest with them. The chapters describe the basic reaction mechanisms, and the influence of iodine introduction on physical/chemical and pharmacological properties. They include examples of important reaction pathways for the preparation of radio-iodine compounds.
One of the most successful thinking skills books on the market by a bestselling author New edition includes 18 new entries, with many others revised New, pocket-sized format with bright cover will increase appeal beyond the academic market
Personalized medicine employing patient-based tailor-made therapeutic drugs is taking over treatment paradigms in a variety of ?elds in oncology and the central nervous system. The success of such therapies is mainly dependent on ef?cacious therapeutic drugs and a selective imaging probe for identi?cation of potential responders as well as therapy monitoring for an early bene?t assessment. Molecular imaging (MI) is based on the selective and speci?c interaction of a molecular probe with a biological target which is visualized through nuclear, magnetic resonance, near infrared or other methods. Therefore it is the method of choice for patient selection and therapy monitoring as well as for sp...
The work describes the production technology of standard medical radionuclides using reactors and cyclotrons for patient diagnosis and therapy. A special focus lies on the science and technology involved in the development of novel radionuclides for positron emission tomography (PET) and internal targeted radiotherapy. The availability of those radionuclides is opening up new potential in clinical research, especially in neurology, cardiology and oncology. The future perspectives of the developing technology are also discussed.